tradingkey.logo
tradingkey.logo
검색

Conmed Corp

CNMD
관심 목록에 추가
33.830USD
+1.070+3.27%
종가 07/02, 13:00ET시세는 15분 지연됩니다
1.02B시가총액
19.08P/E TTM

자세한 내용은 Conmed Corp 회사

CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

Conmed Corp 정보

종목 코드 CNMD
회사 이름Conmed Corp
상장일Jul 23, 1987
CEOBeyer (Patrick J)
직원 수3900
유형Ordinary Share
회계 연도 종료Jul 23
주소11311 Concept Boulevard
도시LARGO
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호33773
전화17272142974
웹사이트https://www.conmed.com/
종목 코드 CNMD
상장일Jul 23, 1987
CEOBeyer (Patrick J)

Conmed Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.91K
+3.73%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
--
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
6.45K
+10.35%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
--
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--
Mr. Brent Lalomia
Mr. Brent Lalomia
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
1.04K
-8.65%
Mr. Charles (Chuck) Farkas
Mr. Charles (Chuck) Farkas
Independent Director
Independent Director
--
--
Ms. Johonna Marie Pelletier
Ms. Johonna Marie Pelletier
Treasurer and Vice President - Tax
Treasurer and Vice President - Tax
--
--
Mr. Todd W. Garner
Mr. Todd W. Garner
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.91K
+3.73%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
--
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
6.45K
+10.35%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
--
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--

자주 묻는 질문

Conmed Corp의 상위 5대 주주는 누구인가요?

Conmed Corp의 상위 5대 주주는 다음과 같습니다: Mr. David M. Bronson

Conmed Corp(CNMD)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Conmed Corp의 주식을 보유한 기관은 총 638곳이며, 이들이 보유한 주식의 총 가치는 약 34.51M로 전체 발행 주식의 114.61%를 차지합니다. 이는 2025Q4 대비 -7041128.00 증가한 수치입니다.

Conmed Corp의 최대 수익원은 무엇인가요?

2026Q1 기준, Conmed Corp의 General Surgery 부문이 가장 높은 매출을 기록했으며, 금액은 800.13M로 전체 매출의 58.20%를 차지했습니다.